#icaredoa

Our iCARE DOA Rapid Screen Tests offer highly sensitive and specific drug detection using monoclonal antibodies for precise identification of drugs of abuse (DOA) and their metabolites in urine samples. Designed with lateral flow immunoassay technology, these rapid, qualitative screening devices meet regulatory standards for cut-off concentrations, ensuring reliable and accurate results. As manufacturers, exporters, and bulk suppliers, we provide trusted solutions for efficient drug screening.